AUSTIN, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery ...

Omnicell beat analysts’ revenue expectations by 2.2% last quarter, reporting revenues of $306.9 million, up 18.6% year on year. It was a slower quarter for the company, with EBITDA guidance for ...

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q1 CY2025 results topping the market’s revenue expectations , with sales up 9.6% year on year to $269.7 million. On the other hand, ...

Wells Fargo upgraded Omnicell (NASDAQ:OMCL) to Overweight from Equal Weight on Wednesday, citing a compelling risk-reward setup in the shares of the Fort Worth, Texas-based vendor of pharmacy ...

CEO Randall Lipps highlighted strong Q1 2025 performance driven by demand for Omnicell's medication management platform. Key focus areas included market share growth in inpatient and outpatient ...

Ratings for Omnicell (NASDAQ:OMCL) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table encapsulates their recent ratings ...

FORT WORTH, Texas - Omnicell, Inc. (NASDAQ:OMCL), a $1.35 billion market cap healthcare technology company known for its pharmacy and nursing care solutions, has introduced a new line of products ...

FORT WORTH, Texas (AP) — FORT WORTH, Texas (AP) — Omnicell Inc. (OMCL) on Tuesday reported a loss of $7 million in its first quarter. On a per-share basis, the Fort Worth, Texas-based company ...